Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00AOJ
|
|||
| Former ID |
DAP001249
|
|||
| Drug Name |
Docosanol
|
|||
| Synonyms |
Abreva; Debat; Doconsanol; Erazaban; Healip; Herepair; Lidakol; Lidavol; Tadenan; Behenic alcohol; Behenyl alcohol; Docosanol [USAN]; Docosyl alcohol; IK 2; Lanette 22; NAA 422; Stenol 1822; Stenol 1822A; Abreva (TN); Docosanol (USAN); Docosanol (VAN); Erazaban (TN); IK.2; N-Docosanol; Nacol 22-97; V-1326;BEHENYL ALCOHOL, 98%; Docosan-1-ol; Behenyl alcohol, Abreva, 1-Docosanol, Docosanol; Behenyl alcohol, AI3-36489, Behenic alcohol, 1-Docosanol, Docosyl alcohol, IK-2, Tadenan; 1-DOCOSANOL
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Herpes simplex virus infection [ICD-11: 1F00; ICD-10: B00; ICD-9: 54] | Approved | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Company |
Avanir Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H46O
|
|||
| Canonical SMILES |
CCCCCCCCCCCCCCCCCCCCCCO
|
|||
| InChI |
1S/C22H46O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23/h23H,2-22H2,1H3
|
|||
| InChIKey |
NOPFSRXAKWQILS-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 661-19-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
74102, 588002, 616715, 3137145, 4438509, 7850367, 8147876, 8159457, 10532037, 12014691, 14801707, 17397968, 24850264, 24867521, 29215292, 29215293, 29280827, 39906031, 46508049, 48417683, 49834540, 49964430, 50064663, 51072445, 57327731, 57392285, 77913665, 85084045, 87567551, 92297716, 92308152, 92717789, 103770436, 104253273, 104329499, 117427434, 117620019, 118308991, 121400730, 124757395, 124892111, 125164199, 125332263, 125563274, 126628726, 126653678, 126674705, 127268411, 127319986, 127319987
|
|||
| ChEBI ID |
CHEBI:31000
|
|||
| ADReCS Drug ID | BADD_D00700 | |||
| SuperDrug ATC ID |
D06BB11
|
|||
| SuperDrug CAS ID |
cas=000661198
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Epstein-Barr virus Envelope glycoprotein gp340 (EBV BLLF1) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 020941. | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.